Skip to content

Varicella-Zoster Virus IgG Control Serum BC104G

$94.00

Summary

  • Virion/Serion Diagnostic Kit Control for research use (RUO)
  • Varicella-Zoster Virus IgG Control Serum
  • Applications: ELISA
  • IgG control serum
  • Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
  • 3 mL
Weight 1 lbs
Dimensions 9 × 5 × 2 in
target

Varicella-Zoster Virus reactive IgG

species reactivity

Varicella-Zoster Virus

applications

ELISA

assay type

Indirect & quantitative

available size

3 mL

Varicella-Zoster Virus IgG Control Serum BC104G

kit
Research area
Infectious Disease
Storage
Store at 2-8°C.
Associated products
Varicella Zoster Virus (VZV) Envelope Glycoprotein E Control Antigen (BA104R02)
Varicella-Zoster Virus Antigen (BA104VS)
Varicella-Zoster Virus Glycoprotein Antigen (BA104VSG)
Varicella-Zoster Virus IgA Control Serum (BC104A)
Varicella-Zoster Virus IgG Control Serum (BC104G)
Varicella-Zoster Virus IgM Control Serum (BC104M)
Varicella-Zoster Virus IgA ELISA Kit (ESR104A)
Varicella-Zoster Virus IgG ELISA Kit (ESR104G)
Varicella-Zoster Virus IgM ELISA Kit (ESR104M)
target relevance
Organism
Varicella-Zoster Virus
Protein names
Varicella-ZosterVirus
Structure and strains
Varicella zoster virus (VZV), also known as human herpesvirus 3 (HHV-3, HHV3) or Human alphaherpesvirus 3 (taxonomically), is one of nine known herpes viruses that can infect humans. It causes chickenpox (varicella) commonly affecting children and young adults, and shingles (herpes zoster) in adults but rarely in children. VZV infections are species-specific to humans. The virus can survive in external environments for a few hours.

VZV multiplies in the tonsils, and causes a wide variety of symptoms. Similar to the herpes simplex viruses, after primary infection with VZV (chickenpox), the virus lies dormant in neurons, including the cranial nerve ganglia, dorsal root ganglia, and autonomic ganglia. Many years after the person has recovered from initial chickenpox infection, VZV can reactivate to cause shingles.
Detection and diagnosis
IgG as well as IgM and, in most cases, also IgA antibodies are produced within a few days following the regular course of a primary infection with VZV. In cases of Herpes zoster, IgG and IgA concentrations rise rapidly within a few days of disease onset. In most cases, IgM antibody activity is also detectable once more

Data

Publications

Publications

pmid title authors citation
We haven't added any publications to our database yet.
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC104G protocol

Documents

#
Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information.